Page 25 - Jourmal of World Association of Laparoscopic Surgeon

WJOLS

What Should be the Approach in the Long-term Management of Patients with Gastroesophageal Reflux Disease?

Again these theoretical possibilities has not established in discontinuation of therapy. Hence, a treatment option which
the clinical settings. provides effective control of symptoms and prevents or
GERD is a chronic condition and just like any other minimizes complications has to be offered to patients.
chronic syndrome patients with GERD also require Medical therapy with PPI and laparoscopic antireflux
prolonged medication. The consensus on pathophysiology surgery, both can achieve these therapeutic goals. Hence,
of GERD is breakdown of antireflux barrier in patients with in the light of this literature review it is recommended to
GERD, and PPIs or other medications effective in individualize the treatment offered to the patient with
controlling GERD symptoms fail to address this primary GERD, in consultation with the patient himself or herself.
cause of the disease. This is a major criticism leveled against
prolonged use of PPIs by proponents of surgery for GERD. REFERENCES
In addition there are several large studies which has shown 1. Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E,
that the clinical outcome of laparoscopic antireflux surgery Modlin IM, et al. American gastroenterological association
medical position statement on the management of gastro-
is more favorable than that of long-term PPI therapy. Other esophageal reflux disease. Gastroenterology 2008;135:1383-91.
studies also have demonstrated that laparoscopic Nissen 2. Nebel OT, Fornes ME, Castell DO. Symptomatic gastro-
fundoplication provides better physiological control of esophageal reflux: Incidence and precipitating factors. Am J
reflux and improved quality of life. Dig Dis 1976;21(11):953-56.
As noted earlier, GERD is syndrome which represents 3. DeMeester TR, Johnson LF, Joseph GJ, Toscano MS, A Hall
AW, Skinner DB. Patterns of gastroesophageal reflux in health
nonerosive reflux disease and erosive and ulcerative and disease. Annals Surg 1976;184(4):459-70.
gastroesophageal disease. Hence, there are studies which 4. Nandurkar S, Talley NJ. Epidemiology and natural history of
have challenged the superiority of antireflux surgery in the reflux disease. Baillieres Best Pract Res Clin Gastroenterol
2000;14(5):743-57.
treatment of esophagitis. These studies have demonstrated 5. Hunt RH, Tytgat GH, Malfertheiner P, et al. Whistle summary:
that recurrence rate of esophagitis between antireflux The slow rate of rapid progress. J Clin Gastroenterol 2007;41(6):
surgery and PPI are equal and healing of esophagitis is also 539-45.
similar. Similarly, controversy exists in the management of 6. Little AG. Mechanisms of action of antireflux surgery: Theory
and fact. World J Surg 1992;16:320-25.
Barretts esophagus. In this regard, earlier studies have shown 7. Ireland AC, Holloway RH, Toouli J, Dent J. Mechanisms
laparoscopic antireflux surgery to be the choice for patients underlying the antireflux action of fundoplication. Gut 1993;34:
with Barrets esophagus, as it reconstructs the antireflux 303-08.
barrier, and following surgery regression of intestinal 8. Vakil N. The frontiers of reflux disease. Dig Dis Sci 2006;51(11):
1887-95.
metaplasia has been observed and it also appeared to reduce 9. Lundell L. Acid suppression in the long-term treatment of peptic
the risk of adenocarcinoma. But a recent meta-analysis has strictures in Barrett’s oesophagus. Digestion 1992;51(suppl 1):
failed substantiate such a protective effect against 49-58.
development of esophageal cancer in patients with Barretts 10. Dallemagne B, Weerts JM, Jehaes C, Markiewicz S, Lombard R.
Laparoscopic Nissen fundoplication: Preliminary report. Surg
esophagus following antireflux surgery. Laparosc Endosc 1991;1(3):138-43.
Endoluminal procedures have been recently evolving 11. Watson DI, Jamieson GG. Antireflux surgery in the laparoscopic
in an interesting and promising less invasive procedures era. Br J Surg 1998;85:1173-84.
than laparoscopic antireflux surgery. However, significant 12. Carlson MA, Frantzides CT. Complications and results of
data is lacking about these procedures and there are no primary minimally invasive antireflux procedures: A review of
10, 735 reported cases. J Am Coll Surg 2001;193:428-39.
studies that have compared the efficacy of these procedures 13. Harvey RF, Hadley N, Gill TR, et al. Effects of sleeping with
with either antireflux surgery or with medical treatments. the bed-head raised and of ranitidine in patients with severe
peptic oesophagitis. The Lancet 1987;2(8569):1200-03.
CONCLUSION 14. Harris RA, Kuppermann M, Richter JE. Proton pump inhibitors
or histmine 2 receptor antagonists for the prevention of
GERD is a syndrome resulting from breakdown of antireflux recurrences of erosive esophagitis: A cost effectiveness analysis.
barrier at the lower end of esophagus. This breakdown of Am J Gastroenterol 92(12):2179-87.
antireflux barrier results in reflux of gastric contents into 15. Sachs G. Proton pump inhibitors and acid-related diseases.
Pharmacotherapy 17(1):22-37.
the esophagus. Mechanisms for the antireflux barrier 16. Horn J. The proton-pump inhibitors: Similarities and differences.
breakdown are thought to be due to TLESRs and hiatus Clin Ther 22(2):266-80.
hernia. 17. Venables TL, Newland RD, Patel AC, et al. Omeprazole 10 mg
PPIs is an option for initial management of GERD. once daily, omeprazole 20 mg once daily or ranitidine 150 mg
However, this condition been a chronic condition, relapse twice daily, evaluated as initial therapy for the relief of symptoms
of gastroesophageal reflux disease in general practice. Scand J
is common while on therapy with medications or following Gastroenterol 1997;32:965-73.
World Journal of Laparoscopic Surgery, January-April 2013;6(1):23-28 27